Omaha Alzheimer's Walk Raises $225,000 for Families

Omaha residents affected by Alzheimer's now have local education, support groups, and research funded by the walk's fundraising.

Updated on Nov. 2, 2026 in Alzheimer’s

Omaha Alzheimer's Walk Raises $225,000 for Families

More than 1,500 people attended the 2026 Omaha Walk to End Alzheimer's on Sunday, October 11, at Flames Fieldhouse on the College of Saint Mary campus, raising more than $225,000 for local education, support groups, and research. The event is a community fundraiser that funds programs for families living with the disease in the Omaha area.

Why it matters

Alzheimer's and dementia are growing burdens, and local fundraising pays for the education and support services families rely on day to day. The FDA has approved several newer medications over the last four years that target the underlying biology of the disease, a shift that makes early conversations with a doctor more relevant for people concerned about memory.

The figures combine event attendance and fundraising totals with national prevalence estimates for Alzheimer's and dementia. The 2060 figure of 13.8 million is a projection that assumes no cure arrives before then.

The players

Alzheimer's Association

The leading national voluntary health organization focused on Alzheimer's care, support, and research, which runs the Walk to End Alzheimer's events and operates a 24/7 helpline.

Food and Drug Administration

The federal agency that reviews and approves prescription drugs, including the Alzheimer's medications that target the disease's underlying biology.

The details

The Omaha walk closes with a ceremony in which a white flower is raised in hope of the first survivor of Alzheimer's, marking the event's goal of eventually ending the disease. Funds raised support local education programs, support groups, and research, with Don Woods serving on the executive leadership committee for the 2026 walk. The newer FDA-approved medications target the underlying biology of the disease rather than only easing symptoms.

Timeline

  1. Sunday, October 11, 2026: 2026 Omaha Walk to End Alzheimer's held at Flames Fieldhouse

  2. Over the last four years: FDA approved multiple Alzheimer's treatments targeting underlying biology

  3. 2060: projected rise to 13.8 million Americans with Alzheimer's or dementia without a cure

Health Landscape

Local walks like this one feed the Alzheimer's Association's national research and support work, which has grown alongside FDA approval of newer drugs that target disease biology. The projected rise to 13.8 million affected Americans by 2060 shows why sustained community funding remains part of the picture.

If you or a family member have noticed memory changes, it is worth raising them with a doctor, since newer FDA-approved medications and early evaluation are now part of the conversation. Local support groups funded by events like this one can also help caregivers navigate daily challenges.

The takeaway

Local fundraising supports the education and support services that help families manage Alzheimer's day to day. If memory concerns arise, a conversation with your physician and a call to the Alzheimer's Association helpline are reasonable first steps.

Further reading

For more on treatment options and care planning, explore our Alzheimer's coverage.

More information

Find education, support, and the 24/7 helpline (1-800-272-3900) through the Alzheimer's Association.

Source note: This article includes information reported by Flatwater Free Press.